• EN/ES

    Orthopedics

    WebHealthNetwork : 2,378,479


  • Benefits & Savings

  • : Anaplastic Astrocytoma

Anaplastic Astrocytoma - 216 Studies Found

Completed : Super-Selective Intraarterial Intracranial Infusion of Avastin (Bevacizumab)
:
  • Glioblastoma Multiforme
  • Anaplastic Astrocytoma

: 2009-08-26
: Drug: Super-Selective Intraarterial Intracranial Infusion of BEVACIZUMAB
Completed : Repeated Super-selective Intraarterial Cerebral Infusion of Bevacizumab (Avastin) for Treatment of Relapsed GBM and AA
:
  • Glioblastoma Multiforme
  • Anaplastic Astrocytoma

: 2010-12-22
:
  • Drug: Bevacizumab

Active, not recruiting : P2/3 Randomized Study of Toca 511 & Toca FC Versus SOC in Subjects Undergoing Surgery for Recurrent GBM/AA
:
  • Glioblastoma Multiforme
  • Anaplastic Astrocytoma

: 2015-04-03
:
  • Biological: Toca 511 Toca 511

Completed : Antineoplaston Therapy in Treating Adult Patients With Anaplastic Astrocytoma
: Adult Brain Tumor
: 1999-11-01
: Drug: Antineoplaston therapy (Atengenal + Astugenal) Adults with an anaplastic astrocytoma will receive
Completed : Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Anaplastic Astrocytoma
: Brain and Central Nervous System Tumors
: 1999-11-01
:
  • Drug: carmustine
  • Drug: cisplatin

Active, not recruiting : Radiation Therapy Combined With Chemotherapy in Treating Patients With Anaplastic Astrocytoma or Mixed Gliomas
: Brain and Central Nervous System Tumors
: 2000-01-28
:
  • Drug: Nitrosourea (BCNU or CCNU)
  • Drug: tem

Completed : Leflunomide in Treating Patients With Anaplastic Astrocytoma in First Relapse
: Brain and Central Nervous System Tumors
: 1999-11-01
: Drug: leflunomide
Completed : Phase IIa Safety and Light Dose-escalation Study in Patients With Primary or Recurrent/High-grade Glioma Using the Litx™ System to Confirm the Zone of Tumor Destruction During the Intraoperative Treatment of Glioma
:
  • Glioma
  • Glioblastoma Multiforme
  • Anapl
    : 2006-12-07
    :
    • Drug: LS11 (talaporfin sodium)
    • Device: Lig

Terminated : Phase II Study of Irinotecan HCI for Recurrent Anaplastic Astrocytomas, Mixed Malignant Gliomas, and Oligodendrogliomas
:
  • Astrocytoma
  • Glioma
  • Oligodendroglioma

: 2006-08-03
:
  • Drug: Irinotecan Hydrochloride (HCI) Treatment

Completed : Super-Selective Intraarterial Cerebral Infusion of Cetuximab (Erbitux) for Treatment of Relapsed/Refractory GBM and AA
:
  • Glioblastoma Multiforme (GBM)
  • ANAPLASTIC ASTROCYTOMA (AOA)

  • : 2010-11-04
    : Drug: Superselective Intraarterial Cerebral Infusion of Cetuximab Intraarterial Mannitol 25% 3-10 ml to
<<< Previous | Next >>>
Orthopedics Health
Orthopedics Health WebHealth Network Media
  • WebHealthNetwork
  • DiabetesHealthMatters
  • HeartandStrokeHealth
  • WomensHealthCareCommunity
  • AsthmaHealthCenter
  • CancerHealthCenter
  • MentalHealthHelpCenter
  • Skincarehealthcenter
  • DigestiveTractHealth
  • VaccineHealthCenter
  • PainHealthCenter
  • FightingAddictionCenter
  • ObesityHealthMatters
  • SeniorHealthcareMatters
  • BrainAndNerveCenter
  • PediatricsHealthCenter
  • RareDiseasesHealthCenter
  • Wealth Mason
  • Home Owners Circle
  • EasyInsuranceFinder
  • EduJumpStart
  • SaleSpider
  • ScoopCafe
  • SaleSpiderMedia
  • Viewpoint.World
  • TravelerBooked
  • TechNewsBytes
  • Contact Us
  • Advertising Privacy Policy

This site uses cookies for analytics and advertising. No personal information is collected.

© Orthopedics Health .

We use cookies to enhance your experience, analyze anonymized traffic, and deliver personalized content and ads. No personal information is collected. By using our website, you consent to our use of cookies and agree to our data practices as described in our Privacy Policy. To Reject, please change your browser settings.